A study to test a single administration of three dose levels of ATX101 in healthy adults.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-521999-56-00

Acronym

ATX101-CLN-1001

Enrollment

Registered

2025-07-07

Start date

2025-07-16

Completion date

2025-10-24

Last updated

2025-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of vascular hyperpermeability in patients with sepsis and septic shock.

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Portugal

None listed

Source: EU CTIS · Data processed: Feb 4, 2026